Copyright Reports & Markets. All rights reserved.

Global 3D Multimodality Imaging Market Growth (Status and Outlook) 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global 3D Multimodality Imaging Market Size 2017-2028
    • 2.1.2 3D Multimodality Imaging Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 3D Multimodality Imaging Segment by Type
    • 2.2.1 PET-CT
    • 2.2.2 SPECT-CT
    • 2.2.3 PET-MR
    • 2.2.4 OCT
    • 2.2.5 Other
  • 2.3 3D Multimodality Imaging Market Size by Type
    • 2.3.1 3D Multimodality Imaging Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global 3D Multimodality Imaging Market Size Market Share by Type (2017-2022)
  • 2.4 3D Multimodality Imaging Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Diagnostic Centers
    • 2.4.3 Other
  • 2.5 3D Multimodality Imaging Market Size by Application
    • 2.5.1 3D Multimodality Imaging Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global 3D Multimodality Imaging Market Size Market Share by Application (2017-2022)

3 3D Multimodality Imaging Market Size by Player

  • 3.1 3D Multimodality Imaging Market Size Market Share by Players
    • 3.1.1 Global 3D Multimodality Imaging Revenue by Players (2020-2022)
    • 3.1.2 Global 3D Multimodality Imaging Revenue Market Share by Players (2020-2022)
  • 3.2 Global 3D Multimodality Imaging Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 3D Multimodality Imaging by Regions

  • 4.1 3D Multimodality Imaging Market Size by Regions (2017-2022)
  • 4.2 Americas 3D Multimodality Imaging Market Size Growth (2017-2022)
  • 4.3 APAC 3D Multimodality Imaging Market Size Growth (2017-2022)
  • 4.4 Europe 3D Multimodality Imaging Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa 3D Multimodality Imaging Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas 3D Multimodality Imaging Market Size by Country (2017-2022)
  • 5.2 Americas 3D Multimodality Imaging Market Size by Type (2017-2022)
  • 5.3 Americas 3D Multimodality Imaging Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC 3D Multimodality Imaging Market Size by Region (2017-2022)
  • 6.2 APAC 3D Multimodality Imaging Market Size by Type (2017-2022)
  • 6.3 APAC 3D Multimodality Imaging Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe 3D Multimodality Imaging by Country (2017-2022)
  • 7.2 Europe 3D Multimodality Imaging Market Size by Type (2017-2022)
  • 7.3 Europe 3D Multimodality Imaging Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa 3D Multimodality Imaging by Region (2017-2022)
  • 8.2 Middle East & Africa 3D Multimodality Imaging Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa 3D Multimodality Imaging Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global 3D Multimodality Imaging Market Forecast

  • 10.1 Global 3D Multimodality Imaging Forecast by Regions (2023-2028)
    • 10.1.1 Global 3D Multimodality Imaging Forecast by Regions (2023-2028)
    • 10.1.2 Americas 3D Multimodality Imaging Forecast
    • 10.1.3 APAC 3D Multimodality Imaging Forecast
    • 10.1.4 Europe 3D Multimodality Imaging Forecast
    • 10.1.5 Middle East & Africa 3D Multimodality Imaging Forecast
  • 10.2 Americas 3D Multimodality Imaging Forecast by Country (2023-2028)
    • 10.2.1 United States 3D Multimodality Imaging Market Forecast
    • 10.2.2 Canada 3D Multimodality Imaging Market Forecast
    • 10.2.3 Mexico 3D Multimodality Imaging Market Forecast
    • 10.2.4 Brazil 3D Multimodality Imaging Market Forecast
  • 10.3 APAC 3D Multimodality Imaging Forecast by Region (2023-2028)
    • 10.3.1 China 3D Multimodality Imaging Market Forecast
    • 10.3.2 Japan 3D Multimodality Imaging Market Forecast
    • 10.3.3 Korea 3D Multimodality Imaging Market Forecast
    • 10.3.4 Southeast Asia 3D Multimodality Imaging Market Forecast
    • 10.3.5 India 3D Multimodality Imaging Market Forecast
    • 10.3.6 Australia 3D Multimodality Imaging Market Forecast
  • 10.4 Europe 3D Multimodality Imaging Forecast by Country (2023-2028)
    • 10.4.1 Germany 3D Multimodality Imaging Market Forecast
    • 10.4.2 France 3D Multimodality Imaging Market Forecast
    • 10.4.3 UK 3D Multimodality Imaging Market Forecast
    • 10.4.4 Italy 3D Multimodality Imaging Market Forecast
    • 10.4.5 Russia 3D Multimodality Imaging Market Forecast
  • 10.5 Middle East & Africa 3D Multimodality Imaging Forecast by Region (2023-2028)
    • 10.5.1 Egypt 3D Multimodality Imaging Market Forecast
    • 10.5.2 South Africa 3D Multimodality Imaging Market Forecast
    • 10.5.3 Israel 3D Multimodality Imaging Market Forecast
    • 10.5.4 Turkey 3D Multimodality Imaging Market Forecast
    • 10.5.5 GCC Countries 3D Multimodality Imaging Market Forecast
  • 10.6 Global 3D Multimodality Imaging Forecast by Type (2023-2028)
  • 10.7 Global 3D Multimodality Imaging Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Siemens AG
    • 11.1.1 Siemens AG Company Information
    • 11.1.2 Siemens AG 3D Multimodality Imaging Product Offered
    • 11.1.3 Siemens AG 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Siemens AG Main Business Overview
    • 11.1.5 Siemens AG Latest Developments
  • 11.2 GE Healthcare
    • 11.2.1 GE Healthcare Company Information
    • 11.2.2 GE Healthcare 3D Multimodality Imaging Product Offered
    • 11.2.3 GE Healthcare 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 GE Healthcare Main Business Overview
    • 11.2.5 GE Healthcare Latest Developments
  • 11.3 Koninklijke Philips N.V.
    • 11.3.1 Koninklijke Philips N.V. Company Information
    • 11.3.2 Koninklijke Philips N.V. 3D Multimodality Imaging Product Offered
    • 11.3.3 Koninklijke Philips N.V. 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Koninklijke Philips N.V. Main Business Overview
    • 11.3.5 Koninklijke Philips N.V. Latest Developments
  • 11.4 Bruker Corporation
    • 11.4.1 Bruker Corporation Company Information
    • 11.4.2 Bruker Corporation 3D Multimodality Imaging Product Offered
    • 11.4.3 Bruker Corporation 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Bruker Corporation Main Business Overview
    • 11.4.5 Bruker Corporation Latest Developments
  • 11.5 Canon
    • 11.5.1 Canon Company Information
    • 11.5.2 Canon 3D Multimodality Imaging Product Offered
    • 11.5.3 Canon 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Canon Main Business Overview
    • 11.5.5 Canon Latest Developments
  • 11.6 Mediso
    • 11.6.1 Mediso Company Information
    • 11.6.2 Mediso 3D Multimodality Imaging Product Offered
    • 11.6.3 Mediso 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Mediso Main Business Overview
    • 11.6.5 Mediso Latest Developments
  • 11.7 MILabs B.V.
    • 11.7.1 MILabs B.V. Company Information
    • 11.7.2 MILabs B.V. 3D Multimodality Imaging Product Offered
    • 11.7.3 MILabs B.V. 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 MILabs B.V. Main Business Overview
    • 11.7.5 MILabs B.V. Latest Developments
  • 11.8 MR Solutions
    • 11.8.1 MR Solutions Company Information
    • 11.8.2 MR Solutions 3D Multimodality Imaging Product Offered
    • 11.8.3 MR Solutions 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 MR Solutions Main Business Overview
    • 11.8.5 MR Solutions Latest Developments
  • 11.9 Northridge Tri-Modality Imaging
    • 11.9.1 Northridge Tri-Modality Imaging Company Information
    • 11.9.2 Northridge Tri-Modality Imaging 3D Multimodality Imaging Product Offered
    • 11.9.3 Northridge Tri-Modality Imaging 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Northridge Tri-Modality Imaging Main Business Overview
    • 11.9.5 Northridge Tri-Modality Imaging Latest Developments
  • 11.10 PerkinElmer
    • 11.10.1 PerkinElmer Company Information
    • 11.10.2 PerkinElmer 3D Multimodality Imaging Product Offered
    • 11.10.3 PerkinElmer 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 PerkinElmer Main Business Overview
    • 11.10.5 PerkinElmer Latest Developments
  • 11.11 Heidelberg Engineering
    • 11.11.1 Heidelberg Engineering Company Information
    • 11.11.2 Heidelberg Engineering 3D Multimodality Imaging Product Offered
    • 11.11.3 Heidelberg Engineering 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Heidelberg Engineering Main Business Overview
    • 11.11.5 Heidelberg Engineering Latest Developments
  • 11.12 Infraredx (Nipro Corporation)
    • 11.12.1 Infraredx (Nipro Corporation) Company Information
    • 11.12.2 Infraredx (Nipro Corporation) 3D Multimodality Imaging Product Offered
    • 11.12.3 Infraredx (Nipro Corporation) 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Infraredx (Nipro Corporation) Main Business Overview
    • 11.12.5 Infraredx (Nipro Corporation) Latest Developments
  • 11.13 Neusoft Medical Systems
    • 11.13.1 Neusoft Medical Systems Company Information
    • 11.13.2 Neusoft Medical Systems 3D Multimodality Imaging Product Offered
    • 11.13.3 Neusoft Medical Systems 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Neusoft Medical Systems Main Business Overview
    • 11.13.5 Neusoft Medical Systems Latest Developments
  • 11.14 Spectrum Dynamics Medical
    • 11.14.1 Spectrum Dynamics Medical Company Information
    • 11.14.2 Spectrum Dynamics Medical 3D Multimodality Imaging Product Offered
    • 11.14.3 Spectrum Dynamics Medical 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Spectrum Dynamics Medical Main Business Overview
    • 11.14.5 Spectrum Dynamics Medical Latest Developments
  • 11.15 Topcon Corporation
    • 11.15.1 Topcon Corporation Company Information
    • 11.15.2 Topcon Corporation 3D Multimodality Imaging Product Offered
    • 11.15.3 Topcon Corporation 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 Topcon Corporation Main Business Overview
    • 11.15.5 Topcon Corporation Latest Developments
  • 11.16 Zeiss Group
    • 11.16.1 Zeiss Group Company Information
    • 11.16.2 Zeiss Group 3D Multimodality Imaging Product Offered
    • 11.16.3 Zeiss Group 3D Multimodality Imaging Revenue, Gross Margin and Market Share (2020-2022)
    • 11.16.4 Zeiss Group Main Business Overview
    • 11.16.5 Zeiss Group Latest Developments

12 Research Findings and Conclusion

Multimodal imaging or multiplexed imaging refers to simultaneous production of signals for more than one imaging technique. For example, one could combine using optical, magnetic, and radioactive reporters to be detected by SPECT, MRI, and PET.

The global market for 3D Multimodality Imaging is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC 3D Multimodality Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States 3D Multimodality Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe 3D Multimodality Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China 3D Multimodality Imaging market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key 3D Multimodality Imaging players cover Siemens AG, GE Healthcare, Koninklijke Philips N.V., Bruker Corporation and Canon, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global 3D Multimodality Imaging market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global 3D Multimodality Imaging market, with both quantitative and qualitative data, to help readers understand how the 3D Multimodality Imaging market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the 3D Multimodality Imaging market and forecasts the market size by Type (PET-CT, SPECT-CT and PET-MR), by Application (Hospitals, Diagnostic Centers and Other,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
PET-CT
SPECT-CT
PET-MR
OCT
Other

Segmentation by application
Hospitals
Diagnostic Centers
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Siemens AG
GE Healthcare
Koninklijke Philips N.V.
Bruker Corporation
Canon
Mediso
MILabs B.V.
MR Solutions
Northridge Tri-Modality Imaging
PerkinElmer
Heidelberg Engineering
Infraredx (Nipro Corporation)
Neusoft Medical Systems
Spectrum Dynamics Medical
Topcon Corporation
Zeiss Group

Chapter Introduction
Chapter 1: Scope of 3D Multimodality Imaging, Research Methodology, etc.
Chapter 2: Executive Summary, global 3D Multimodality Imaging market size and CAGR, 3D Multimodality Imaging market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 3D Multimodality Imaging revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 3D Multimodality Imaging revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 3D Multimodality Imaging market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Siemens AG, GE Healthcare, Koninklijke Philips N.V., Bruker Corporation, Canon, Mediso, MILabs B.V., MR Solutions and Northridge Tri-Modality Imaging, etc.
Chapter 14: Research Findings and Conclusion

Buy now